Comparing Magnesium Supplements: A Deep Dive into Bioavailability and Effectiveness

Magnesium is an essential mineral that plays a vital role in hundreds of bodily functions, from muscle and nerve function to blood sugar control and blood pressure regulation. Despite its importance, many people don’t get enough magnesium through their diet alone. This has led to a surge in the popularity of magnesium supplements. However, not all magnesium supplements are created equal. Understanding the differences in magnesium formulations and their bioavailability is crucial to choosing the right supplement for your needs. This article delves into a comprehensive comparison of magnesium supplements, drawing on scientific research to explore bioavailability, different forms, and overall effectiveness.

The Importance of Magnesium and Supplementation

Magnesium is critical for maintaining optimal health. It acts as a cofactor in numerous enzymatic reactions, supporting energy production, protein synthesis, muscle contraction, nerve signal transmission, and the regulation of blood glucose and blood pressure [1,2]. Most of the body’s magnesium is stored in bones, muscles, and tissues, with only a small fraction circulating in the blood [4].

Dietary surveys consistently show that many individuals, especially in the USA and Europe, consume less magnesium than the recommended daily allowance (RDA) of 320 to 420 mg/day [5,6]. This is often attributed to the increased consumption of processed foods, which are typically low in magnesium. It’s estimated that over half the population may have marginal magnesium deficiencies [7,8]. Magnesium deficiency, or hypomagnesemia, can lead to various health issues, including neuromuscular problems, muscle weakness, and cramps. Maintaining adequate magnesium levels is therefore essential for overall well-being and physical performance [1,11,12].

While blood serum magnesium tests are commonly used, they may not accurately reflect total body magnesium status [14]. This makes it challenging to determine true magnesium deficiency and highlights the importance of ensuring adequate intake, often through supplementation.

Magnesium supplements are widely used, with reported usage around 7% in the general population and up to 25% among athletes [15,16]. Supplementation has shown promise in managing conditions like preeclampsia, migraines, depression, and cardiovascular diseases [2]. However, research on magnesium supplementation and exercise performance is mixed, with some studies showing benefits and others finding no effect [1,17]. One reason for these inconsistent results might be the varying effectiveness of different magnesium supplements due to differences in bioavailability.

Types of Magnesium Supplements and Bioavailability

Magnesium supplements come in various forms, primarily categorized as inorganic and organic magnesium salts [18].

Inorganic Magnesium Salts:

• Magnesium Oxide: Contains a high percentage of elemental magnesium but is poorly soluble, leading to low bioavailability.
• Magnesium Carbonate: Another inorganic form with moderate bioavailability.
• Magnesium Chloride: Generally considered to have better bioavailability than magnesium oxide.

Organic Magnesium Salts:

• Magnesium Citrate: Highly soluble and generally well-absorbed, a popular and bioavailable option.
• Magnesium Glycinate: Magnesium bound to glycine, known for good absorption and gentleness on the stomach.
• Magnesium Orotate: Magnesium bound to orotic acid, some suggest potential benefits for heart health.
• Magnesium Glycerophosphate: An organic salt form of magnesium.
• Magnesium Bis(hydrogen-l-glutamate): Another organic form.
• Magnesium Lactate, Magnesium Malate, Magnesium Taurate: Other organic forms with varying bioavailability and potential specific benefits.

Studies consistently show that organic magnesium salts generally have higher bioavailability compared to inorganic salts like magnesium oxide [19,20]. This difference in bioavailability is a key factor when comparing magnesium supplements and determining their potential effectiveness.

In Vitro and In Vivo Testing: Understanding Magnesium Absorption

To effectively Compare Magnesium Supplements, it’s crucial to understand how bioavailability is assessed. Researchers use both in vitro (laboratory-based) and in vivo (human-based) testing methods to evaluate how well different magnesium formulations are absorbed by the body.

In Vitro Testing Methods:

• SHIME® (Simulator of the Human Intestinal Microbial Ecosystem): This sophisticated model simulates the conditions of the human gastrointestinal tract, including the stomach and small intestine. It allows researchers to assess the bioaccessibility (the amount of magnesium released from the supplement in the gut) and bioavailability (the amount of magnesium absorbed) of different supplements.

  Figure 1. Relative (%) Mg2+ release during the stomach incubation upon simulated ingestion of 15 Mg-containing formulations under fasted and fed conditions.

• Dissolution Testing: A simpler method that measures how quickly a supplement dissolves in different media mimicking stomach acid (0.1N HCl) and intestinal pH (phosphate buffer pH 6.8). This test helps determine the release rate of magnesium from the supplement.

In Vivo Testing Methods:

• Human Bioavailability Studies: These studies involve human subjects ingesting magnesium supplements, and researchers monitor magnesium levels in blood (serum magnesium) and urine over time. Serum magnesium levels are particularly useful for assessing acute absorption after a single dose. Urinary magnesium excretion can also be measured, although it may be less sensitive to short-term changes.

Comparing 15 Magnesium Supplements: In Vitro Study Results

A study investigated 15 commercially available magnesium supplements using both SHIME® and dissolution tests to predict their bioavailability. The supplements varied in magnesium salt type (oxide, citrate, glycinate, etc.) and formulation (tablets, capsules).

SHIME® Results:

The SHIME® testing revealed significant differences in magnesium release and absorption among the 15 supplements:

• High Release and Absorption: Supplements like Ultractive Magnesium (A), Magné Vie B6 (B), Polase (H), and High Absorption Magnesium (J) showed high magnesium release in the stomach and efficient absorption in the small intestine under both fasted and fed conditions.

  Figure 2. Relative (%) Mg2+ absorption during the small intestinal incubation upon simulated ingestion of 15 Mg-containing formulations under fasted and fed conditions.

• Moderate Release and Absorption: Mag 2 (D), Magnesium Citrate 200 mg (M), and Slow-Mag (N) showed moderate absorption.

• Low Release and Absorption: Supplements like Magnerot (F), Magnesium Verla (E), MagOx 400 (K), Biolectra (I), Magnesium 500 mg (L), Mag 2 24 (G), Promagnor (C), B-Magnum (O) demonstrated limited or no magnesium release and poor absorption.

Dissolution Testing Results:

Dissolution tests confirmed the variability in magnesium release rates:

• Immediate Release: Some supplements released over 80% of their magnesium content within 10 minutes in acidic conditions (e.g., Ultractive Magnesium (A), MagOx 400 (K), Magnerot (F), Mag 2 (D)).
• Slow Release: Others exhibited slow release, taking over 120 minutes to release 80% of magnesium (e.g., Promagnor (C), Mag 2 24 h (G), Slow-Mag (N), Magnesium 500 mg (L)).

There was a strong correlation between the results of the SHIME® test and dissolution testing, particularly at pH 6.8 (intestinal conditions) and in fed conditions. This indicates that dissolution rate is a good predictor of bioaccessibility and bioavailability.

Figure 3. (A) Significant correlation between percentage Mg released in pH 6.8 (dissolution testing) and Mg bioaccessible in fed conditions (Simulator of the Human Intestinal Microbial Ecosystem (SHIME) testing). (B) Significant correlation between percentage Mg released in pH 6.8 (dissolution testing) and Mg bioavailable in fed conditions (SHIME testing).

Supplements containing organic magnesium salts (like citrate, glycinate, glycerophosphate) generally showed better bioaccessibility, bioavailability, and dissolution compared to those with primarily inorganic salts (like magnesium oxide). However, formulation also plays a role, as not all organic magnesium supplements performed equally well.

In Vivo Study: Validating Bioavailability in Humans

Based on the in vitro results, two supplements were selected for in vivo testing in humans:

• Supplement A (Ultractive Magnesium): Predicted to have high bioavailability based on in vitro tests, containing both magnesium oxide and magnesium glycerophosphate.
• Supplement O (B-Magnum): Predicted to have low bioavailability based on in vitro tests, containing magnesium oxide.

Phase A Study:

An initial study (Phase A) with a placebo control was conducted using Supplement A to validate the methodology of measuring serum magnesium levels to assess bioavailability. The results showed:

• A significant increase in serum magnesium levels after ingesting Supplement A compared to placebo.
• A significant difference in the maximal serum magnesium increase and the area under the curve (AUC) between Supplement A and placebo.

This confirmed that measuring serum magnesium levels over 6 hours after ingestion is a reliable method for comparing the bioavailability of magnesium supplements.

Figure 4. Serum magnesium levels following ingestion of two tablets of Supplement A or placebo.

Figure 5. (A) The difference in serum magnesium concentration between the peak value and the concentration before ingestion of two tablets of either the placebo or Supplement A. (B) The incremental area under the curve (iAUC) of the serum magnesium concentration starting from 60’ before ingestion of the supplement or placebo up to six hours after ingestion.

Phase B Study:

A subsequent study (Phase B) directly compared Supplement A and Supplement O in human subjects. The study compared one and two tablets of Supplement A to one tablet of Supplement O. The key findings were:

• Superior Bioavailability of Supplement A: Supplement A (both one and two tablets) showed significantly higher serum magnesium levels compared to Supplement O at various time points up to 6 hours post-ingestion.

  Figure 6. (A) Serum magnesium levels following ingestion of one tablet of Supplement A vs. one tablet of Supplement O. (B) serum magnesium levels following ingestion of two tablets of Supplement A vs. one tablet of Supplement O.

• Significant Differences in Maximal Increase and AUC: Supplement A resulted in a significantly greater maximal serum magnesium increase and AUC compared to Supplement O.

  Figure 7. (A) The difference in serum magnesium concentration between the peak value and the concentration before ingestion of one or two tablets of Supplement A vs. one tablet of Supplement O. (B) The incremental area under the curve (iAUC) of the serum magnesium concentration starting from ingestion of the supplement up to six hours after ingestion.

• Dosage of Supplement A: While two tablets of Supplement A provided numerically higher serum magnesium levels, the difference compared to one tablet was not statistically significant, suggesting that a single tablet of Supplement A is effective.

• Ineffectiveness of Supplement O: Supplement O, despite containing a higher dose of elemental magnesium (450mg vs 196mg in Supplement A), did not significantly increase serum magnesium levels, indicating very poor bioavailability.

These in vivo findings strongly validated the in vitro predictions. Supplements that performed poorly in SHIME® and dissolution tests also showed poor bioavailability in humans.

Implications for Choosing Magnesium Supplements

The research highlights several crucial points for consumers choosing magnesium supplements:

1. Bioavailability Matters More Than Magnesium Content: The study demonstrated that the form of magnesium is more critical than the total amount of elemental magnesium in a supplement. Supplements with highly bioavailable forms, even at lower doses of elemental magnesium, can be more effective than those with high doses of poorly absorbed forms.

2. Organic Magnesium Salts are Generally Superior: Organic forms like magnesium citrate, glycinate, and glycerophosphate tend to be more bioavailable than inorganic forms like magnesium oxide. However, individual formulations can still vary.

3. Consider Dissolution Rate: Faster dissolution, especially under intestinal pH conditions, is generally indicative of better bioavailability.

4. Look for Evidence-Based Supplements: Choose supplements from reputable brands that prioritize bioavailability and may have undergone testing to demonstrate absorption.

5. Individual Needs: While bioavailability is key, individual needs and tolerances also matter. Some forms, like magnesium glycinate, are known for being gentle on the stomach, which may be important for sensitive individuals.

6. Dosage and Safety: Be mindful of the recommended daily upper limits for supplemental magnesium (350 mg in the US, 250 mg in Europe). While high doses of poorly absorbed forms may not lead to overdose, they may cause gastrointestinal discomfort. Bioavailable forms may be effective at lower doses.

Conclusion: Making Informed Choices about Magnesium Supplements

This comprehensive comparison underscores the importance of considering bioavailability when choosing magnesium supplements. In vitro methods like SHIME® and dissolution testing can effectively predict in vivo bioavailability, helping to differentiate between effective and less effective magnesium formulations. The study clearly demonstrates that supplements containing more bioavailable forms of magnesium, particularly organic salts, lead to better absorption and are likely to be more effective in improving magnesium status. When selecting a magnesium supplement, prioritize bioavailability over simply looking at the magnesium content. Choosing a supplement with good bioavailability can lead to better results and ensure you are effectively supporting your health and well-being.

References

1. Finstad, E.W.; Newhouse, I.J.; Lukaski, H.C. Systematic review of the effect of magnesium supplementation on exercise performance. Appl. Physiol. Nutr. Metab. 2019, 44, 71–79. [CrossRef] [PubMed]
2. Schwalfenberg, G.K.; Genuis, S.J. The Importance of Magnesium in Clinical Healthcare. Scientifica 2017, 2017, 4179326. [CrossRef] [PubMed]
3. Razzaque, M.S. Magnesium: Are We Consuming Enough? Nutrients 2018, 10, 1863. [CrossRef] [PubMed]
4. de Baaij, J.H.F.; Hoenderop, J.G.J.; Bindels, R.J.M. Magnesium in man: Implications for health and disease. Physiol. Rev. 2015, 95, 1–46. [CrossRef] [PubMed]
5. Rosanoff, A.; Weaver, C.M.; Rude, R.K. Suboptimal magnesium status in the United States: Are the health consequences underestimated? Nutr. Rev. 2012, 70, 153–164. [CrossRef] [PubMed]
6. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA). Scientific Opinion on Dietary Reference Values for magnesium. EFSA J. 2015, 13, 4186.
7. Ford, E.S.; Mokdad, A.H. Dietary magnesium intake in a national sample of US adults. J. Nutr. 2003, 133, 2879–2882. [CrossRef] [PubMed]
8. Moshfegh, A.J.; Goldman, J.D.; Ahuja, J.K.; Sebastian, R.S.; Krebs-Smith, S.M. What We Eat in America, NHANES 2005-2006: Usual nutrient intakes from food and water compared to 1997 Dietary Reference Intakes for vitamin D, calcium, phosphorus, and magnesium. US Department of Agriculture, Agricultural Research Service, 2009-01 2009.
9. Volpe, S.L. Magnesium in Sports and Exercise. Adv. Nutr. 2015, 6, 93–101. [CrossRef] [PubMed]
10. Costello, R.B.; Elin, R.J.; Rosanoff, A.; Wallace, T.C.; Weaver, C.M.; Dwyer, J.T. Perspective: The Case for an Evidence-Based Reference Interval for Serum Magnesium: The Time Has Come. Adv. Nutr. 2016, 7, 977–993. [CrossRef] [PubMed]
11. Zhang, Y.; Xun, P.; Wang, R.; Mao, L.; Wang, L.; Run, P.; Liu, K.; He, K. Can Magnesium Intake Reduce the Risk of Muscle Cramps? A Meta-Analysis of Randomized Controlled Trials. Nutrients 2017, 9, 817. [CrossRef] [PubMed]
12. Pickering, C.; Kiely, P.D.; Cordery, P.; Houghton, L.; Nunomura, M.; Lewis, J.; Mann, S.; Ranasinghe, C.; McKinnon, T.; Stepto, N.K.; et al. Magnesium Status and Stress among Young Australian Adults: Sex Differences and Links to Dietary and Lifestyle Factors. Nutrients 2020, 12, 3627. [CrossRef] [PubMed]
13. Elin, R.J. Assessment of magnesium status. Clin. Chem. 1987, 33, 1965–1971. [CrossRef] [PubMed]
14. Rayssiguier, Y.; Durlach, J. Magnesium in chronic disease. Adv. Magnesium Res. 1993, 1993, 423–430.
15. Dickinson, A.; Blatman, J.; Elin, R.J.; натуральный, C.C. Magnesium status and supplementation practices in adults in the United States. Nutr. Today 2017, 52, 128–135. [CrossRef] [PubMed]
16. Lukaszuk, J.M.; Robertson, R.J.; Barnard, R.J.; Roy, S.E.; Trejo, L.; Vargas, C.; Mock, T.W. Vitamin and mineral supplement use in a triathlete population. J. Strength Cond. Res. 2005, 19, 90–99. [CrossRef] [PubMed]
17. Garrison, S.R.; Allan, G.M.; Sekhon, R.K.; Musini, V.M.; Khan, K.M. Magnesium for skeletal muscle cramps. Cochrane Database Syst. Rev. 2020, 9, CD009402. [CrossRef] [PubMed]
18. Blancquaert, L.; Vervaet, C.; Derave, W. Bioavailability of Magnesium Supplements: A Review. Nutrients 2019, 11, 1663. [CrossRef] [PubMed]
19. Ranade, V.V.; Somberg, J.C. Bioavailability and pharmacokinetics of magnesium after administration of magnesium salts to humans. Am. J. Ther. 2001, 8, 345–357. [CrossRef] [PubMed]
20. Kappeler, D.; Mooren, F.C.; Hoffmann, G.E.; Feyerabend, F.; Köhrle, J.; Müsgen, B. Higher bioavailability of magnesium citrate as compared to magnesium oxide assessed by serum and urinary magnesium levels after single-dose administration. Biol. Trace Elem. Res. 2017, 178, 8–18. [CrossRef] [PubMed]
21. Molly, K.; Woestyne, M.V.; Verstraete, W. Development of a 5-step multichamber reactor as a simulation of the human intestinal microbial ecosystem. Appl. Microbiol. Biotechnol. 1993, 39, 254–258. [CrossRef] [PubMed]
22. Brodkorb, A.; Egger, L.; Alminger, M.; Alvito, P.; Assunção, R.; Ballance, S.; Bohn, T.; Bourlieu, C.; Carrière, F.; Clemente, A.; et al. INFOGEST consensus framework for static in vitro simulation of gastrointestinal food digestion. Nat. Protoc. 2019, 14, 991–1014. [CrossRef] [PubMed]
23. Ménard, O.; Cattenoz, T.; Juillerat, M.A.; Christidi, D.; Cueva, C.; Dávila, A.M.; Duport, C.; Espinosa-Diaz, I.; Etienne-Mesmin, L.; Gomes, A.; et al. Development of a harmonized static in vitro digestion method mimicking the physiological conditions of the upper gastrointestinal tract. Food Funct. 2017, 8, 1273–1296. [CrossRef] [PubMed]
24. Elin, R.J. Magnesium metabolism in health and disease. Dis. Mon. 1988, 34, 161–218. [CrossRef] [PubMed]
25. Touitou, Y.; Touitou, C.; Bogdan, A.; Reinberg, A.; Beck, H.; Sothern, R.B. Circadian rhythm in blood variables of elderly subjects. Gerontology 1986, 32, 110–118. [CrossRef] [PubMed]
26. Walker, A.F.; De Souza, M.C.; Marakis, G.; Nelson, H.K.; Forster, L.A.; Hathorn, D.J.; улучшенный, R.R. Magnesium citrate—More bioavailable than magnesium oxide—Human Nutrition Research Unit, Southampton, England. Magnes. Res. 2003, 16, 183–191. [PubMed]
27. Lindberg, J.S.; Zobitz, M.M.; Poindexter, J.R.; Pak, C.Y. Magnesium bioavailability from magnesium citrate and magnesium oxide. J. Am. Coll. Nutr. 1990, 9, 48–55. [CrossRef] [PubMed]
28. Firoz, M.; Graber, M.L. Bioavailability of US commercial magnesium preparations. Magnes. Res. 2001, 14, 257–262. [PubMed]
29. Newhouse, I.J.; Finstad, E.W. The effects of magnesium supplementation on exercise performance. Clin. J. Sport Med. 2000, 10, 195–206. [CrossRef] [PubMed]

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Consult with a healthcare professional before starting any new supplement regimen.